Home » Topics » Regulatory » Patents

Patents
RSS

ViiV Healthcare patents compounds to treat HIV infection

Feb. 8, 2016

Pfizer discloses phosphodiesterase 4B inhibitors

Feb. 8, 2016

Lupin divulges MEK inhibitors

Feb. 5, 2016

Zhejiang Kanglaite Group reports natural antitumor from Job's tears

Feb. 5, 2016

Pfizer describes TrKA inhibitors

Feb. 5, 2016

Innov17 develops ROR-alpha/ROR-gamma modulators

Feb. 5, 2016

Chinese scientists patent FXIa inhibitors

Feb. 5, 2016

Shionogi reports ITK inhibitors

Feb. 4, 2016

Merck & Co. develops ROMK channel blockers

Feb. 4, 2016

Bayer Schering Pharma patents GLUT-1 inhibitors

Feb. 4, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...